Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/860730/000119312521048994/d37951d10k.htm
April 2024
April 2024
February 2024
February 2024
February 2024
January 2024
November 2023
October 2023
July 2023
July 2023
Exhibit 99.1
FOR IMMEDIATE RELEASE | ||
INVESTOR CONTACT: | MEDIA CONTACT: | |
Mark Kimbrough | Harlow Sumerford | |
615-344-2688 | 615-344-1851 |
HCA Healthcare Reports Fourth Quarter 2020 Results
and Provides 2021 Guidance
Company Reinstates and Increases Quarterly Dividend;
Resumes Share Repurchase Program and
Increases Authorization
Nashville, Tenn., February 2, 2021 HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the fourth quarter ended December 31, 2020.
Key fourth quarter metrics (all percentage changes compare 4Q 2020 to 4Q 2019 unless otherwise noted):
| Revenues totaled $14.293 billion |
| Net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share |
| Adjusted EBITDA totaled $3.118 billion |
| Cash flows used in operating activities totaled $3.583 billion (includes the return, or early repayment, of over $6 billion in CARES Act funds) |
| Same facility admissions and same facility equivalent admissions declined 3.4 percent and 7.5 percent, respectively |
In the face of the highest surge yet of the COVID-19 pandemic, we finished the year with strong financial results in the fourth quarter. These results were driven, once again, by highly acute inpatient volumes coupled with solid cost management, said Sam Hazen, Chief Executive Officer of HCA Healthcare. We are incredibly proud of our colleagues and our accomplishments in 2020, which included returning over $6 billion of CARES Act funds to the federal government. Our performance this past year gives us confidence to believe that we will be able to navigate successfully through future challenges as well.
Revenues in the fourth quarter of 2020 increased to $14.293 billion, from $13.523 billion in the fourth quarter of 2019. Net income attributable to HCA Healthcare, Inc. totaled $1.426 billion, or $4.13 per diluted share, compared to $1.071 billion, or $3.09 per diluted share, in the fourth quarter of 2019.
1
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/860730/000119312521048994/d37951d10k.htm
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Hca Healthcare, Inc..
Hca Healthcare, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2021 10-K Annual Report includes:
Rating
Learn More
A 2.5% change in the expected claim severity trend could be reasonably likely and would increase the reserve estimate by $126 million or reduce the reserve estimate by $116 million.
We believe adequate reserves have been recorded for our professional liability claims; however, due to the complexity of the claims, the extended period of time to resolve the claims and the wide range of potential outcomes, our ultimate liability for professional liability claims could change by more than the estimated sensitivity amounts and could change materially from our current estimates.
A 2.5% change in the expected frequency trend could be reasonably likely and would increase the reserve estimate by $26 million or reduce the reserve estimate by $25 million.
Our facilities are insured by our 100% owned insurance subsidiary for losses up to $50 million per occurrence; however, this coverage is subject, in most cases, to a $15 million per occurrence self-insured retention.
The $240 million decline in interest expense for 2020 was due to declines in both the average debt balance and the effective interest rate.
The $240 million decline in...Read more
We believe the declines in...Read more
During March 2020, we used...Read more
During March 2020, we used...Read more
We receive a significant portion...Read more
Adverse changes in the percentage...Read more
However, if payments due upon...Read more
The decline in net income...Read more
Other operating expenses are primarily...Read more
Changes in our professional liability...Read more
Borrowings under the senior secured...Read more
The 5.9% increase for 2019...Read more
Outpatient surgical volumes declined 12.6%...Read more
Interest expense declined to $1.584...Read more
Our provisions for income taxes...Read more
Our provisions for income taxes...Read more
Our provisions for income taxes...Read more
The increase in revenues in...Read more
At December 31, 2020, we...Read more
During 2019, we had a...Read more
MANAGEMENT'S DISCUSSION AND ANALYSIS OF...Read more
Both average daily census and...Read more
The $841 million increase in...Read more
Results of Operations Revenue/Volume Trends...Read more
Revenues increased to $51.533 billion...Read more
Revenues increased 0.4% to $51.533...Read more
Revenues increased 0.4% to $51.533...Read more
The average effective interest rate...Read more
Depreciation expense was $2.693 billion...Read more
Our facilities are insured by...Read more
The effective tax rates were...Read more
Texas currently operates its Healthcare...Read more
Achieve Industry-Leading Performance in Clinical,...Read more
If the realization of unrecognized...Read more
Management continually reviews the contractual...Read more
The insurance subsidiary has obtained...Read more
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Material Contracts, Statements, Certifications & more
Hca Healthcare, Inc. provided additional information to their SEC Filing as exhibits
Ticker: HCA
CIK: 860730
Form Type: 10-K Annual Report
Accession Number: 0001193125-21-048994
Submitted to the SEC: Fri Feb 19 2021 4:28:21 PM EST
Accepted by the SEC: Fri Feb 19 2021
Period: Thursday, December 31, 2020
Industry: General Medical And Surgical Hospitals